Medical Bacteriology MBIO 460 Lecture 11 Dr. Turki Dawoud 2 nd Semester 1436/1437 H.

Slides:



Advertisements
Similar presentations
Host Defenses, Microbial Evasion & Virulence Factors
Advertisements

Complement Terry Kotrla, MS, MT(ASCP)BB Fall 2007.
Essentials of Virology
Microbial Interactions with Humans
Pathogenesis. Fig KOCH’S POSTULATES Tools: Diseased animal Healthy animal Red blood cell Observe blood/tissue under the microscope Red blood cell.
Mechanisms of Pathogenicity Microbiology 2314 Definitions Pathogenicity The ability of a pathogen to produce a disease by overcoming the defenses of.
Host Microbe Relationship Patricia Sidelsky 2007.
Define a Few Words: Pathogen Pathology Pathologist Pathogenicity Pathogenesis.
Infectious Disease. Pathogens are microorganisms that cause disease. A host is any organism that is capable of supporting the nutritional and physical.
Bacterial Physiology (Micr430) Lecture 18 Bacterial Pathogenesis (Based on other textbooks such as Madigan’s)
Summary of Lecture 20 Microbe: human interactions on and within the body are normal. Human body is a good habitat for suitable bacteria (nutrients, temperature,
Requisites for Successful Growth Attachment Nutrition Survival from host defence Transmission.
Virulence factors of Bacteria that cause disease Submitted By : Nesren alkakhrass Supervised By: Dr. Abedelraouf A. Elmanama ( Ph.sc Microbiology.
Microbial Mechanisms of Pathogenicity
Game Plan Lecture Lab Disease pathogenesis SSE Unknowns
General Microbiology (Micr300)
Biology 431 Gram (+) Cocci Chapters Staphylococcus Major groups - coagulase (+) aureus vs. (-) others. External Structures Capsule - polysaccharide,
Medical bacteriology:
Toipc Number Seven Mechanism of Bacterial Damage and Bacterial Toxins
Bacterial Toxins Chapter 14 Add-on.
Gram Positive Bacteria and Clinical Case Studies II
Pathogenesis of infectious disease. Path means disease Pathogens refer to microorganism capable to cause a disease. Pathology : the study of structural.
Chapter 14 Pathology. Definitions! Pathology – study of disease Etiology – cause of disease Pathogenicity – how a pathogen overcomes host defenses to.
1077 MCB 3020, Spring 2005 Host-Parasite Relationships.
Microbial Mechanisms of Pathogenicity
PHARMACEUTICAL MICROBIOLOGY -1I PHT 313
Microbial Mechanisms of Pathogenicity
Medical biology, microbiology, virology, immunology department by As.Prof. O.V. Pokryshko Microbial Mechanisms of Pathogenicity.
Chapter 15 Microbial Mechanism of Pathogenicity. Pathogens have to enter the system to cause disease Regions/areas of the body used by microbes to enter.
Pathogenic Gram-Positive Cocci (Staphylococci)
Copyright © 2010 Pearson Education, Inc. MICROBIAL MECHANISMS OF PATHOGENICITY Chapter 15.
Microbial Mechanisms of Pathogenicity
Overview of Pathogenesis (= the manner in which disease develops.) 1)Transmission 2)Portals of Entry 3)Adherence 4)Multiplication & Spread host mechanisms.
Chapter 15 Microbial Mechanisms of Pathogenicity
Plate 49 Establishment of Disease. Skin Epithelium – outer part of skin Epi: “on” Theli: “tissue” Densely packed cells protect body from invading pathogens.
Mechanisms of microbial disease
Medical Microbiology Chapter 19 Mechanisms of Bacterial Pathogenesis.
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case M I C R.
CHAPTER 1 - INTRODUCTION. CONTENT 1) A brief history of medical microbiology 2) Host – parasite relationships 3) Mechanism of pathogenesis  Pathogenic.
Viruses Gene Regulation results in differential Gene Expression, leading to cell Specialization.
MECHANISM OF BACTERIAL PATHOGENICITY
Reservoirs and vectors Reservoirs Animal, soil, water etc - source of infection. Vectors Arthropods, especially fleas, ticks, and mosquitoes Mechanical.
Chapter 17 Host- Microbe Interaction Biology 261 Medgar Evers College, CUNY Prof. Santos.
Methods by which pathogens cause disease: Adhesion: bacteria must bind to the cell surfaces Colonization: bacteria produce proteins and colonize parts.
Viruses In 2009, a general outbreak (epidemic) of a flu- like illness first appeared in Mexico and the United States – Caused by an influenza virus H1N1.
Staphylococci DON XAVIER N.D.  Cocci.  Gram positive.  Non motile.  On NA they form pigmented colonies.  Haemolytic.  Enzyme production.  Ferment.
Mechanisms of Pathogenicity  Pathogenicity: the ability to cause disease  Virulence: the extent of pathogenicity.
Streptococcus IMPORTANT PROPERTIES 1-streptococci are spherical gram-positive cocci. 2-arranged in chain or pairs. 3-all streptococci are catalase negative.
 Antimicrobial agents share certain common properties.  We can learn much about how these agents work and why they sometimes do not work by considering.
Microbial toxin There are several virulence factors which help to establish disease The virulence of some bacteria is thought to be aided by the production.
Medical Bacteriology MBIO 460 Lecture 9 Dr. Turki Dawoud 2 nd Semester 1436/1437 H.
Biochemical tests of Gram positive bacteria
The Staphylococci.
PATHOGENIC EFFECTS OF BACTERIA
Chapter 16 Host- Microbe Interaction
Pathogenesis of infectious disease
Pathogenesis of Infectious Diseases
Mechanism of Pathogenicity
Mechanism of Pathogenicity
Pathogenicity of Microorganisms
Microbial Mechanisms of Pathogenicity
Streptococcus pyogenes
Chapter 15 Microorganisms and Human Disease
Virulence factors of Bacteria that cause disease Submitted By : Nesren alkakhrass Supervised By: Dr. Abedelraouf A. Elmanama ( Ph.sc Microbiology.
Microbial Mechanisms of Pathogenicity
Complement Complement proteins become activated when they encounter antigen Cascading enzyme reactions concentrate activated complement at infection site.
Pathogenic Gram-Positive Cocci (Staphylococci)
Viruses.
Presentation transcript:

Medical Bacteriology MBIO 460 Lecture 11 Dr. Turki Dawoud 2 nd Semester 1436/1437 H

Virulence Factors and Toxins  Extracellular capsules and slime layers, cell wall and envelope material, and fimbriae and pili are all integral macromolec-ular components of microorganisms that may aid in pathogenesis and act as virulence factors.  However, in addition to these, a number of microbial intracellular and extracellular components function solely as virulence factors. These specialized virulence factors are produced by different pathogens, but many share molecular characteristics and modes of action. Here we examine some key factors

Virulence Factors Many pathogens produce toxins, which we discuss in the following three sections. Many other virulence factors are enzymes that enhance pathogen colonization and growth. For example, streptococci, staphylococci, and certain clostridia produce hyaluronidase (Table 28.4), an enzyme that promotes spreading of organisms in tissues by breaking down the polysaccharide hyaluronic acid, a material that functions in animals as an intercellular cement. Hyaluronidase digests the intercellular matrix, enabling these organisms to spread from an initial infection site. Streptococci and staphylococci also produce proteases, nucleases, and lipases that degrade host proteins, nucleic acids, and lipids. Similarly, clostridia that cause gas gangrene produce collagenase, or κ-toxin (Table 28.4), which breaks down the tissue-supporting collagen network, enabling these organisms to spread through the body.

Fibrin, Clots, and Virulence Fibrin is a protein that functions in the clotting of blood, and thus fibrin clots are often formed by the host at a site of microbial invasion. The clotting mechanism, triggered by tissue injury, isolates the pathogens, limiting infection to a local region. Some pathogens counter this process by producing fibrinolytic enzymes that dissolve the clots and make further invasion possible. One fibrinolytic substance produced by Streptococcus pyogenes is called streptokinase (Table 28.4). By contrast, other pathogens produce enzymes that promote the formation of fibrin clots. These clots localize and protect the organism. The best-studied fibrin-clotting enzyme is coagulase (Table 28.4), produced by pathogenic Staphylococcus aureus. Coagulase causes fibrin to be deposited on S. aureus cells, protecting them from attack by host cells. The fibrin matrix produced as a result of coagulase activity probably accounts for the extremely localized nature of many staphylococcal infections, as in boils and pimples (Figure 34.24). Coagulase-positive S. aureus strains are typically more virulent than coagulase-negative strains.

Toxins 1.Exotoxins 2.Enterotoxin 3.Endotoxin

Exotoxins Exotoxins are toxic proteins released from the pathogen cell as it grows. These toxins travel from a site of infection and cause damage at distant sites. Table 28.4 provides a summary of the properties and actions of some of the known exotoxins as well as other extracellular virulence factors. Exotoxins fall into one of three categories: the cytolytic toxins, the AB toxins, and the super-antigen toxins. The cytolytic toxins work by degrading cytoplasmic membrane integrity, causing lysis. The AB toxins consist of two subunits, A and B. The B component generally binds to a host cell surface receptor, allowing the transfer of the A subunit across the targeted cell membrane, where it damages the cell. The superantigens work by stimulating large numbers of immune cells, resulting in extensive inflammation and tissue damage, as we will discuss later (Section 30.8)

Cytolytic Toxins Various pathogens produce proteins that damage the host cytoplasmic membrane, causing cell lysis and death. Because the activity of these toxins is most easily observed with assays involving the lysis of red blood cells (erythrocytes), the toxins are called hemolysins (Table 28.4). However, they also lyse cells other than erythrocytes. The production of hemolysin is demonstrated in the laboratory by streaking the pathogen on a blood agar plate (a rich medium containing 5% whole blood). During growth of the colonies, hemolysin is released and lyses the surrounding red blood cells, releasing hemoglobin and creating a clearing, called hemolysis (Figure 28.18).

Figure Hemolysis. (a) Zones of hemolysis around colonies of Streptococcus pyogenes growing on a blood agar plate. (b)Action of lecithinase, a phospholipase, around colonies of Clostridium perfringens growing on an agar medium containing egg yolk, a source of lecithin. Lecithinase dissolves the membranes of red blood cells, producing the cloudy zones of hemolysis around each colony

Some hemolysins attack the phospholipid of the host cytoplasmic membrane. Because the phospholipid lecithin (phosphatidylcholine) is often used as a substrate, these enzymes are called lecithinases or phospholipases. An example is the α-toxin of Clostridium perfringens, a lecithinase that dissolves membrane lipids, resulting in cell lysis (Table 28.4, Figure 28.18b; Figure 21.41). Because the cytoplasmic membranes of all organisms contain phospholipids, phospholipases sometimes destroy bacterial as well as animal cytoplasmic membranes. Some hemolysins, however, are not phospholipases. Streptolysin O, a hemolysin produced by streptococci, affects the sterols of the host cytoplasmic membrane. Leukocidins (Table 28.4) lyse white blood cells and may decrease host resistance (Section 29.2).

Staphylococcal α-toxin (Figure and Table 28.4) kills nucleated cells and lyses erythrocytes. Toxin subunits first bind to the lipid bilayer. The subunits then oligomerize into nonlytic heptamers, now associated with the membrane. Following oligomerization, each heptamer undergoes conformational changes to produce a membrane-spanning pore, releasing the cell contents and allowing influx of extracellular material, disrupting cell function and causing cell death.

Protein Synthesis Inhibitor Toxins Several pathogens produce AB exotoxins that inhibit protein synthesis. Diphtheria toxin, produced by Corynebacterium diphtheriae, is a good example of an AB toxin and is an important virulence factor. Rats and mice are relatively resistant to diphtheria toxin, but human, rabbit, guinea pig, and bird cells are very susceptible, with only a single toxin molecule required to kill each cell. Diphtheria toxin is secreted by cells of C. diphtheriae as a single polypeptide. Fragment B specifically binds to a host cell receptor (Figure 28.20). After binding, proteolytic cleavage between fragment A and B allows entry of fragment A into the host cytoplasm. Here fragment A disrupts protein synthesis by blocking transfer of an amino acid from a tRNA to the growing polypeptide chain (Section 7.15). The toxin specifically inactivates elongation factor 2, a protein involved in growth of the polypeptide chain, by catalyzing the attachment of adenosine diphosphate (ADP) ribose from NAD +. Following ADP-ribosylation, the activity of the modified elongation factor 2 decreases dramatically and protein synthesis stops

Diphtheria toxin is formed only by strains of C. diphtheriae that are lysogenized by a bacteriophage called phage β; the tox gene in the phage genome encodes the toxin. Non-toxigenic, non-pathogenic strains of C. diphtheriae can be converted to pathogenic strains by infection with phage β (this is a process called phage conversion, Section 10.10). Exotoxin A of Pseudomonas aeruginosa functions similarly to diphtheria toxin, also modifying elongation factor 2 by ADP- ribosylation (Table 28.4)

QUESTIONS??